| Widespread deregulation of microRNA expression in human prostate cancer M Ozen, CJ Creighton, M Ozdemir, M Ittmann Oncogene 27 (12), 1788-1793, 2008 | 816 | 2008 |
| LNCaP progression model of human prostate cancer: Androgen‐independence and osseous metastasis GN Thalmann, RA Sikes, TT Wu, A Degeorges, SM Chang, M Ozen, ... The Prostate 44 (2), 91-103, 2000 | 444 | 2000 |
| Interleukin-6 is an autocrine growth factor in human prostate cancer D Giri, M Ozen, M Ittmann The American journal of pathology 159 (6), 2159-2165, 2001 | 430 | 2001 |
| The role of fibroblast growth factors and their receptors in prostate cancer B Kwabi-Addo, M Ozen, M Ittmann Endocrine-related cancer 11 (4), 709-724, 2004 | 427 | 2004 |
| Establishment of two human prostate cancer cell lines derived from a single bone metastasis. NM Navone, M Olive, M Ozen, R Davis, P Troncoso, SM Tu, D Johnston, ... Clinical cancer research: an official journal of the American Association …, 1997 | 314 | 1997 |
| Genes that affect brain structure and function identified by rare variant analyses of Mendelian neurologic disease E Karaca, T Harel, D Pehlivan, SN Jhangiani, T Gambin, ZC Akdemir, ... Neuron 88 (3), 499-513, 2015 | 305 | 2015 |
| Human CLP1 mutations alter tRNA biogenesis, affecting both peripheral and central nervous system function E Karaca, S Weitzer, D Pehlivan, H Shiraishi, T Gogakos, T Hanada, ... Cell 157 (3), 636-650, 2014 | 212 | 2014 |
| Global transcriptional disturbances underlie Cornelia de Lange syndrome and related phenotypes B Yuan, D Pehlivan, E Karaca, N Patel, WL Charng, T Gambin, ... The Journal of clinical investigation 125 (2), 636-651, 2015 | 184 | 2015 |
| Global gene expression analysis of reactive stroma in prostate cancer O Dakhova, M Ozen, CJ Creighton, R Li, G Ayala, D Rowley, M Ittmann Clinical Cancer Research 15 (12), 3979-3989, 2009 | 183 | 2009 |
| Fibroblast growth factor 2 promotes tumor progression in an autochthonous mouse model of prostate cancer N Polnaszek, B Kwabi-Addo, LE Peterson, M Ozen, NM Greenberg, ... Cancer research 63 (18), 5754-5760, 2003 | 182 | 2003 |
| Hypoxic adipocytes pattern early heterotopic bone formation E Olmsted-Davis, FH Gannon, M Ozen, MM Ittmann, Z Gugala, JA Hipp, ... The American journal of pathology 170 (2), 620-632, 2007 | 154 | 2007 |
| The properties of chopped basalt fibre reinforced self-compacting concrete Z Algin, M Ozen Construction and Building Materials 186, 678-685, 2018 | 149 | 2018 |
| Enhanced survival in perineural invasion of pancreatic cancer: an in vitro approach H Dai, R Li, T Wheeler, M Ozen, M Ittmann, M Anderson, Y Wang, ... Human pathology 38 (2), 299-307, 2007 | 147 | 2007 |
| Steroid receptor coactivator-3 and activator protein-1 coordinately regulate the transcription of components of the insulin-like growth factor/AKT signaling pathway J Yan, CT Yu, M Ozen, M Ittmann, SY Tsai, MJ Tsai Cancer research 66 (22), 11039-11046, 2006 | 139 | 2006 |
| Meta-analysis of miRNA expression profiles for prostate cancer recurrence following radical prostatectomy E Pashaei, E Pashaei, M Ahmady, M Ozen, N Aydin PloS one 12 (6), e0179543, 2017 | 132 | 2017 |
| Conditional activation of fibroblast growth factor receptor (FGFR) 1, but not FGFR2, in prostate cancer cells leads to increased osteopontin induction, extracellular signal … KW Freeman, RD Gangula, BE Welm, M Ozen, BA Foster, JM Rosen, ... Cancer research 63 (19), 6237-6243, 2003 | 100 | 2003 |
| Role of fibroblast growth factor receptor signaling in prostate cancer cell survival M Ozen, D Giri, F Ropiquet, A Mansukhani, M Ittmann Journal of the National Cancer Institute 93 (23), 1783-1790, 2001 | 96 | 2001 |
| Designing a gold nanoparticle‐based nanocarrier for microRNA transfection into the prostate and breast cancer cells A Ekin, OF Karatas, M Culha, M Ozen The journal of gene medicine 16 (11-12), 331-335, 2014 | 95 | 2014 |
| Identification of miR-139-5p as a saliva biomarker for tongue squamous cell carcinoma: a pilot study MB Duz, OF Karatas, E Guzel, NF Turgut, M Yilmaz, CJ Creighton, ... Cellular Oncology 39, 187-193, 2016 | 94 | 2016 |
| Overexpression of miR-145–5p inhibits proliferation of prostate cancer cells and reduces SOX2 expression M Ozen, OF Karatas, S Gulluoglu, OF Bayrak, S Sevli, E Guzel, ID Ekici, ... Cancer investigation 33 (6), 251-258, 2015 | 94 | 2015 |
